LISATA THERAPEUTICS, INC. (LSTA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, LISATA THERAPEUTICS, INC. reported revenue of $170.0K, down 83.0% from the prior year. The company ran a net loss, with a net margin of -9756.5%. It held $17.74M in total assets against $3.14M in total liabilities.
Key ratios (FY2025)
-10711.2%
Operating margin
-9756.5%
Net margin
-113.6%
Return on equity
-83.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $170.0K | $1.00M | $0 | $0 | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — | — | $31.14M |
| Operating Income | -$18.21M | -$22.41M | -$25.71M | -$57.60M | -$29.05M | -$19.14M | -$20.09M | -$16.99M | -$27.59M | -$29.50M |
| Net Income | -$16.59M | -$19.98M | -$20.84M | -$54.23M | -$27.47M | -$8.14M | -$19.35M | -$16.17M | $22.23M | -$33.31M |
| EPS (Diluted) | $-1.91 | $-2.40 | $-2.58 | $-10.47 | $-7.45 | $-0.53 | — | $-1.67 | $2.56 | $-4.99 |
| Total Assets | $17.74M | $35.00M | $54.69M | $73.03M | $97.01M | $36.00M | $27.15M | $44.58M | $63.38M | $53.51M |
| Total Liabilities | $3.14M | $5.68M | $6.80M | $6.71M | $5.01M | $3.76M | $6.60M | $7.13M | $13.19M | $30.05M |
| Shareholders' Equity | $14.60M | $29.32M | $47.89M | $66.32M | $92.00M | $32.24M | $20.55M | $37.45M | $50.19M | $4.07M |
| Cash & Equivalents | $15.96M | $16.21M | $22.59M | $32.15M | $24.65M | $16.51M | $14.03M | $10.30M | $29.16M | $7.08M |
| Operating Cash Flow | -$15.95M | -$19.36M | -$20.03M | -$21.17M | -$22.25M | -$8.82M | -$18.88M | -$19.99M | -$20.88M | -$23.67M |
| Capital Expenditures | $28.0K | $0 | $0 | $285.0K | $60.0K | $20.0K | $0 | $134.0K | $135.0K | $1.10M |
| Shares Outstanding | 8.83M | 8.41M | 8.15M | 7.87M | 3.99M | 19.38M | 10.52M | 9.87M | 9.48M | 8.21M |